Inhibrx Biosciences Files 2024 10-K
Ticker: INBX · Form: 10-K · Filed: Mar 17, 2025 · CIK: 2007919
| Field | Detail |
|---|---|
| Company | Inhibrx Biosciences, Inc. (INBX) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotech, annual-report
TL;DR
Inhibrx dropped its 2024 10-K, check financials for 2024.
AI Summary
Inhibrx Biosciences, Inc. filed its 2024 10-K on March 17, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Ibex SpinCo, Inc. after a name change on January 11, 2024, operates in the biological products sector. The filing details financial data and business operations for the period.
Why It Matters
This 10-K filing provides a comprehensive overview of Inhibrx Biosciences' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Inhibrx Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Previous Fiscal Year (For comparative financial analysis)
- 2022 — Prior Fiscal Year (For longer-term financial trend analysis)
Key Players & Entities
- Inhibrx Biosciences, Inc. (company) — Filer
- Ibex SpinCo, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250317 (date) — Filing date
- 20240111 (date) — Date of name change
FAQ
What was the primary business activity of Inhibrx Biosciences, Inc. during fiscal year 2024?
The company is engaged in the biological products sector, specifically focusing on biological products (no diagnostic substances) as indicated by its SIC code [2836].
When did Inhibrx Biosciences, Inc. change its name from Ibex SpinCo, Inc.?
The company's name was changed from Ibex SpinCo, Inc. to Inhibrx Biosciences, Inc. on January 11, 2024.
What is the business address of Inhibrx Biosciences, Inc.?
The business address is 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA 92037.
What is the SEC file number for Inhibrx Biosciences, Inc.'s 10-K filing?
The SEC file number is 001-42031.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding Inhibrx Biosciences, Inc. (INBX).